Proteolysis-concentrating on chimeras (PROTACs) and molecular glue degraders (MGDs) are probably the most maturely designed TPD techniques. During this evaluation, we focus on both equally preclinical experiments and medical trials to offer a comprehensive summary of the protection and clinical effectiveness of PROTACs and MGDs in hematologic malig